Alcon Reports First Quarter 2021 Results
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2021. For the first quarter of 2021, worldwide sales were
First quarter 2021 key figures |
||||
|
|
Three months ended March 31 |
||
|
|
2021 |
|
2020 |
Net sales ($ millions) |
|
1,910 |
|
1,822 |
Operating margin (%) |
|
|
|
(1.5)% |
Core operating margin (%)(1) |
|
|
|
|
Earnings/(loss) per share ($) |
|
0.17 |
|
(0.12) |
Core diluted earnings per share ($)(1) |
|
0.49 |
|
0.45 |
"The first quarter was a solid start to the year, with healthy sales, a return to 2019 core margin levels and the substantial completion of our separation activities. Strong commercial execution of our new product launches continues to drive market share gains despite the continued impacts of COVID-19," said David Endicott, Chief Executive Officer.
Mr. Endicott continued, "I want to thank the hundreds of Alcon associates who have spent the past two years working to complete our separation and establish our independence as the global leader in eye care. Their extraordinary work is allowing us to devote more time to accelerating innovation and driving above-market sales growth. Our recent success validates our continued investment in a robust product pipeline that will meet the future needs of eye care professionals and their patients."
First quarter 2021 results
Worldwide sales for the first quarter were
The following table highlights net sales by segment for the first quarter of 2021:
|
|
Three months ended March 31 |
|
Change % |
||||
($ millions unless indicated otherwise) |
|
2021 |
|
2020 |
|
$ |
|
cc(2) |
Surgical |
|
|
|
|
|
|
|
|
Implantables |
|
344 |
|
310 |
|
11 |
|
9 |
Consumables |
|
535 |
|
519 |
|
3 |
|
— |
Equipment/other |
|
198 |
|
155 |
|
28 |
|
25 |
Total Surgical |
|
1,077 |
|
984 |
|
9 |
|
7 |
Vision Care |
|
|
|
|
|
|
|
|
Contact lenses |
|
509 |
|
502 |
|
1 |
|
(1) |
Ocular health |
|
324 |
|
336 |
|
(4) |
|
(5) |
Total Vision Care |
|
833 |
|
838 |
|
(1) |
|
(3) |
Net sales to third parties |
|
1,910 |
|
1,822 |
|
5 |
|
2 |
Surgical momentum driven by equipment and implantables
Surgical net sales of
Vision Care impacted by prior year stocking activity
Vision Care net sales of
Operating income
First quarter 2021 operating income was
Diluted earnings per share (EPS)
First quarter 2021 diluted earnings per share were
Balance sheet highlights
The Company ended the first quarter with a cash position of
Financial outlook
The Company provided its full year outlook as follows. This assumes markets return to historical levels in the third quarter and grow in the second half of the year.
|
|
Net sales |
|
Core operating margin(1) |
approximately |
Core diluted EPS(1) |
|
Webcast and Conference Call Instructions
The Company will host a conference call on May 5 at 2:00 p.m. Central European Time / 8:00 a.m. Eastern Time to discuss its first quarter 2021 earnings results. The webcast can be accessed online through Alcon's Investor Relations website, investor.alcon.com. Listeners should log on approximately 10 minutes in advance. A replay will be available online within 24 hours after the event.
The Company's interim financial report and supplemental presentation materials can be found online through Alcon's Investor Relations website at the beginning of the conference, or by clicking on the link:
Footnotes (pages 1-3) |
|
(1) |
Core results, such as core operating margin and core EPS, are non-IFRS measures. For additional information, including a reconciliation of such core r
|